» Articles » PMID: 34079454

Ang II Promotes Cardiac Autophagy and Hypertrophy Via Orai1/STIM1

Overview
Journal Front Pharmacol
Date 2021 Jun 3
PMID 34079454
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The pathophysiology of cardiac hypertrophy is complex and multifactorial. Both the store-operated Ca entry (SOCE) and excessive autophagy are the major causative factors for pathological cardiac hypertrophy. However, it is unclear whether these two causative factors are interdependent. In this study, we examined the functional role of SOCE and Orai1 in angiotensin II (Ang II)-induced autophagy and hypertrophy using neonatal rat cardiomyocytes (NRCMs) and mouse model, respectively. We show that YM-58483 or SKF-96365 mediated pharmacological inhibition of SOCE, or silencing of Orai1 with Orail-siRNA inhibited Ang II-induced cardiomyocyte autophagy both and . Also, the knockdown of Orai1 attenuated Ang II-induced pathological cardiac hypertrophy. Together, these data suggest that Ang II promotes excessive cardiomyocyte autophagy through SOCE/Orai1 which can be the prime contributing factors in cardiac hypertrophy.

Citing Articles

Qingda Granule Attenuates Hypertension-Induced Cardiac Damage via Regulating Renin-Angiotensin System Pathway.

Long L, Tan L, Xu F, Yang W, Li H, Liu J Chin J Integr Med. 2024; .

PMID: 39243318 DOI: 10.1007/s11655-024-3807-4.


STIM1 in tumor cell death: angel or devil?.

Ren R, Li Y Cell Death Discov. 2023; 9(1):408.

PMID: 37932320 PMC: 10628139. DOI: 10.1038/s41420-023-01703-8.


The Current State of Research on Sirtuin-Mediated Autophagy in Cardiovascular Diseases.

Wang Y, Li Y, Ding H, Li D, Shen W, Zhang X J Cardiovasc Dev Dis. 2023; 10(9).

PMID: 37754811 PMC: 10531599. DOI: 10.3390/jcdd10090382.


Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference.

Liu P, Yang Z, Wang Y, Sun A Int J Mol Sci. 2023; 24(17).

PMID: 37685995 PMC: 10487555. DOI: 10.3390/ijms241713188.


STIM1 ablation impairs exercise-induced physiological cardiac hypertrophy and dysregulates autophagy in mouse hearts.

Bonilla I, Baine S, Pokrass A, Mariangelo J, Kalyanasundaram A, Bogdanov V J Appl Physiol (1985). 2023; 134(5):1287-1299.

PMID: 36995910 PMC: 10190841. DOI: 10.1152/japplphysiol.00363.2022.


References
1.
Wollert K, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski C . Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996; 271(16):9535-45. DOI: 10.1074/jbc.271.16.9535. View

2.
Hulot J, Fauconnier J, Ramanujam D, Chaanine A, Aubart F, Sassi Y . Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation. 2011; 124(7):796-805. PMC: 3428713. DOI: 10.1161/CIRCULATIONAHA.111.031229. View

3.
Selvaraj S, Sun Y, Sukumaran P, Singh B . Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Mol Carcinog. 2015; 55(5):818-31. PMC: 4624064. DOI: 10.1002/mc.22324. View

4.
Gupta S, Das B, Sen S . Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2007; 9(6):623-52. DOI: 10.1089/ars.2007.1474. View

5.
Kimura S, Noda T, Yoshimori T . Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007; 3(5):452-60. DOI: 10.4161/auto.4451. View